There are a couple of points here, Mr. Chair.
First and foremost, Canada was one of the first countries, or early countries, to get contracts in place with Pfizer, Moderna and Johnson & Johnson. Experience with others was different, so I'm not sure what the basis for that is.
In terms of booster procurement, we're absolutely in ongoing discussions with all of the suppliers to find out what their future plans are—whether it's a new and different vaccine or a booster to their existing vaccine. Those discussions are indeed under way.